Cogstate Scientific Presentations at CTAD
For 20 years, Cogstate has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and patients around the world, with particular emphasis and experience in Alzheimer’s Disease. We are pleased to be part of the CTAD program.
- Poster: A biomarker to aid Alzheimer’s disease staging: sTREM2 is decreased in Amyloid positive/Tau negative, yet increased once Tau aggregates leading to increased cognitive decline (Paul Maruff, Co-Author)
- Poster: The Pre-Clinical Alzheimer’s Cognitive Composite Score: Informing Clinical Meaningfulness through the Alzheimer’s Disease Continuum (Paul Maruff, Co-Author)
- Poster: Characterising progressive decline across multiple cognitive domains in preclinical Alzheimer’s disease (Paul Maruff, Co-Author)
- Poster: Do Alzheimer’s Risk Genes Also Predict Cognitive Decline? (Paul Maruff, Co-Author)
Cogstate Experts Involved in Presentations